Show
Sort by
-
Endometrial carcinosarcoma
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group
-
- Journal Article
- A1
- open access
Myths and fake messages about human papillomavirus (HPV) vaccination : answers from the ESGO Prevention Committee
-
The IJGC editorial fellowship
-
Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer
-
- Journal Article
- A1
- open access
PORTEC-4a : international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
-
The importance of biomarker expression in addition to lymph node status in the ESMO risk stratification of endometrial cancer
-
Para-aortic lymph node surgical staging in locally-advanced cervical cancer : comparison between robotic versus conventional laparoscopy
-
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment